A few authors, however, report reductions associated with healthy living, but their studies are based on fatal prostate cancer alone [21], or selected subjects with aggressive [22] or advanced cancer [23], or in studies conducted before the prostate specific antibody (PSA) test was introduced [24, 25]. The gene discussed is KLK3; the disease is Familial prostate cancer.